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Purpose: To report a case of successful treatment for severe lipemia retinalis with extreme 
severe hypertriglyceridemia (sHTG).
Design: Observational case report.
Observations: A 6-week-old infant with severe lipemia retinalis manifested diffuse creamy 
retinal vessels complicated with vulvar xanthomas. Extreme sHTG with 185-folds of the normal 
level was reported. Chromosome microarray and lipid gene sequencing confirmed a homozygous 
lipoprotein lipase gene coding mutation.
Results: Under strict adherence to a high medium-chain triglycerides formula and discontinu-
ation of breast milk, the lipemia retinalis and vulval lesions resolved along with a stable plasma 
lipid level throughout the follow-up period of 6 months.
Conclusion: Strict adherence to a low-fat diet without breast milk appears to be effective in 
treating infants with severe lipemia retinalis associated with exceptionally high triglycerides.
Keywords: hypertriglyceride, infant, lipemia retinalis, lipoprotein lipase gene
Introduction
Lipemia retinalis is a rare creamy white discoloration of the retina due to hyperlipid-
emia. It is associated with increased blood viscosity and retinal ischemia that may lead 
to significant visual morbidity.1,2 The severity of the disease is graded anatomically2 
according to the area of the affected vessels. Grade III is the most severe and rarest 
form that affects the periphery toward the optic disc and is characterized by salmon-
colored retina with diffuse milky vessel. Despite the different treatment modalities in 
infantile lipemia retinalis,3–6 there is limited literature regarding the therapeutic efficacy 
in very severe cases. Herein, we obtained written informed consent from the patient’s 
parent to illustrate the images and report an effective treatment for the highest ever 
reported triglyceride (TG) of grade III infantile lipemia retinalis.
Case report
A 6-week-old Hispanic female infant, who was delivered after a full-term uneventful 
pregnancy, presented with emesis and blood-streaked stools for 3 days. Blood testing 
disclosed milky, lipemic serum, and abnormal lipid profiles (Figure 1). Laboratory 
studies reported markedly elevated TG of 316 mmol/L (normal level <1.7 mmol/L) 
via the dilution technique, as the machine was unable to read the high concentration 
of lipids in the blood. Her family history did not reveal any lipid disorders. Her sibling 
and parents were in good health with normal lipid profiles. Other laboratory data, 
including blood cell counts, electrolytes, liver function, thyroid function, glucose, and 
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lipase tests were normal. In addition, liver and spleen size 
were also normal.
Despite the observed severe hypertriglyceridemia 
(sHTG), 185 times of normal level, no xanthelasma was 
observed. The cycloplegic retinoscopy value measured +1.00 
in both eyes. Slit-lamp examination revealed the absence of 
cornea opacity, arcus senilis, crystalline, cataract, and ante-
rior segment xanthoma of either eye. The optical media was 
clear. Fundus examination of both eyes disclosed a whitish 
optic disc, diffuse creamy retinal vessels in peripheral and 
posterior poles, and salmon-pink retina (Figures 2A and B). 
These retinal findings with involvement of all vessels were 
classified clinically as severe (grade III) lipemia retinalis. No 
lipid extravasation, optic disk swelling, vascular sheathing, or 
exudative hemorrhage was found. Chromosome microarray 
showed a large segment of homozygosity of ~12 MB in chro-
mosome 8p23.1p21.3, an area where the LPL gene is found. 
Targeted lipid gene sequencing panel demonstrated one 
homozygous coding mutation in the LPL gene (c.644G>A, 
p.G215E) which confirmed type I hyperlipoproteinemia.
On admission, the patient was treated conservatively with 
breast milk and adequate intravenous hydration combined with 
Enfaport (Mead Johnson Nutrition, Jersey City, NJ, USA), a 
milk protein-based powder that is low in fat and high (84%) 
in medium-chain triglycerides (MCT). On day 8, the TG level 
decreased to 4.5 mmol/L and the patient was discharged with a 
total cholesterol level of 6.5 mmol/L, low-density liproprotein 
4.3 mmol/L, and high-density liproprotein  0.26 mmol/L. A 
week later, the patient was readmitted due to a rebound TG 
level of 56.5 mmol/L, total cholesterol of 43.7 mmol/L, and 
presentation of eruptive vulvar xanthomas ( Figure 3). Mono-
gen (Nutricia, the Netherlands), a formula with similar (80%) 
MCT content was used to replace the Enfaport formula. In 
addition, breastfeeding was ceased to maximize the dietary 
treatment. The vulvar xanthomas self-resolved, and TG and 
cholesterol levels decreased dramatically to 1.75 and 9.3 
mmol/L, respectively, after 1-week treatment with high MCT 
with no breast milk. Intriguingly, the lipemia retinalis had 
resolved completely in both eyes (Figures 2C and D) 3 months 
later. Indeed, the patient remained symptom-free and main-
tained an average TG level of 4.6 mmol/L with a normal fundus 
for a follow-up period of 6 months. She eventually established a 
long-term low-fat semi-solid diet with the high MCT formula.
Discussion
Infantile lipemia retinalis is a rare disease, as most 
reported cases were found in adults in association with 
Figure 1 Lipemic serum after centrifugation.
OD before treatmentA B
C DOD after treatment
OS before treatment
OS after treatment
Figure 2 Lipemia retinalis before and after treatment. Fundus examination disclosed 
bilateral whitish optic discs, diffuse creamy retinal vessels in the peripheral and 
posterior pole OD (A), OS (B), and salmon-pink retina that were identified as signs 
of severe lipemia retinalis before treatment. Fundus examination depicted complete 
bilateral resolution of lipemic retinal vessel disease OD (C), OS (D) after treatment.
Abbreviations: OD, oculus dexter; OS, oculus sinister. 
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 hyperlipoproteinemia.7,8 Currently, there is no clear con-
sensus for a standard treatment of infants presenting with 
sHTG. In this report, we were able to reduce the serum TG 
using high MCT without breast milk in a rare case of extreme 
sHTG. As previously reported, high MCT formula with9 or 
without5,6 breastfeeding was used only to control infants 
with TG level <170 mmol/L. In this case, the extremely high 
serum TG was maintained within asymptomatic ranges after 
the discontinuation of breastfeeding. We thus speculated 
that the high level of long-chain fatty acids in breast milk 
may contribute to the elevation of serum TG in patients 
with extreme sHTG.10 Future studies are needed to support 
our new findings and confirm that using high MCT formula 
without breastfeeding is an effective treatment in infants 
with TG levels >300 mmol/L.
Various studies have demonstrated that lipemia retinalis 
is associated with high TG levels in hyperlipoproteinemias 
types 1, 3, 4, and 5 with different underlying causes.11 
Specifically, the genetic mutation in the primary LPL gene 
produced the type 1 hyperlipoproteinemia seen in this case. 
 However, genotype–phenotype correlations have not been 
established, as there is no strong association between the 
nature or location of the mutation, age at diagnosis, lipid 
levels, and severity of symptoms.12 While some studies 
have suggested that the genetic basis of childhood HTG is 
not confined to a particular type of hyperlipoproteinemia,13 
other studies12 have suggested that TG levels were higher in 
compound heterozygotes compared to homozygotes, which 
was not in our case. Therefore, we speculated that there 
may be other factors, not only the LPL polymorphism for 
determining the TG levels.
Markedly elevated TG in lipemia retinalis might pre-
dispose patients to develop potential ocular complications 
caused by the inner retinal ischemia.14 Although the literature 
has shown that fundus lesions of lipemia retinalis might be 
resolved after appropriate treatment,4–6,9 it remains unknown 
whether future retinal function and vision development may 
be impaired in sHTG infants. Despite the chronic lipid-
lowering therapy used to reverse the clinical manifestation 
of sHTG, maintenance of TG levels with dietary fat restric-
tion or combinational treatment when our patient grows 
through her childhood will be challenging. Further studies 
are needed to evaluate the long-term effect, not only on the 
restoration of normal retina vessel morphology but also on 
the development of vision.
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Figure 3 Eruptive vulvar xanthomas.
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